Blend Labs Inc SEC Filings

Blend Labs, Inc. (BLND) filed a Form 144 notice for the proposed sale of 4,000 shares of common stock. The sale is to be executed through Charles Schwab & Co., Inc. on the NYSE with an approximate sale date of 08/22/2025 and an aggregate market value reported at $14,000. The shares were acquired on 02/20/2025 by restricted stock lapse from Blend Labs, Inc., with payment described as equity compensation. The filing reports 255,696,747 shares outstanding.

The filing also discloses four sales by Winnie Ling in the past three months: 8,000 shares on 07/03/2025 for $28,000; 4,000 on 07/10/2025 for $14,160; 4,000 on 07/24/2025 for $14,360; and 4,000 on 08/07/2025 for $14,477. The filer certifies no undisclosed material adverse information.

Insiders led by Brian N. Sheth and affiliated entities purchased a total of 683,677 shares of Blend Labs, Inc. (BLND) across three trading days. The purchases occurred on 08/18/2025 (38,585 shares at a weighted average price of $2.9736), 08/19/2025 (292,643 shares at $2.9993 weighted average) and 08/20/2025 (222,449 shares at $2.9601 weighted average). An additional 130,000 Class A shares are reported as held indirectly through a family trust. Following these transactions, the reporting group beneficially owned 3,676,919 Class A shares on an indirect basis. The filings identify Haveli Investments, Haveli Brooks Aggregator, Haveli Investments Software Fund I GP, Whanau Interests LLC, related management entities and Mr. Brian N. Sheth as reporting persons.

Brian Kneafsey, Head of Revenue at Blend Labs, reported the sale of 25,000 shares of Class A common stock on 08/15/2025. The sales were made under a Rule 10b5-1 trading plan adopted on March 14, 2025, at a weighted-average price of $2.8749 per share (range $2.85 to $2.9162). After the reported disposition, the reporting person beneficially owns 696,598 shares directly.

The Form 4 indicates the transaction was routine and executed pursuant to a pre-established plan; the filing was signed by an attorney-in-fact on 08/19/2025. No derivative transactions or other classes of securities are reported in this filing.

Ghamsari Nima, a director and the Head of Blend Labs, sold or transferred 311,886 shares of Class A common stock on 08/14/2025 at a reported price of $2.90 per share. After the transaction, he is reported to beneficially own 5,754,051 shares. The Form 4 explains the shares were transferred to a lender in lieu of payments due under his personal loans. The filing was signed by an attorney-in-fact on 08/18/2025. All information below is taken directly from the Form 4 disclosure.

Blend Labs amendment summary: This Amendment No. 1 to the Schedule 13D updates prior disclosures filed May 6, 2024. Reporting persons (Haveli entities and Brian N. Sheth) report beneficial ownership of 60,388,199 shares of Class A common stock, representing 19.3% of the class on the stated basis. The reported holdings comprise 46,153,845 shares issuable on conversion of Series A preferred, 11,111,112 shares issuable on exercise of warrants and 3,123,242 shares of Class A common stock.

Key change: On August 17, 2025 the Board, at Aggregator's request, approved Aggregator acquiring beneficial ownership of up to 24.9% of outstanding Class A shares (previously restricted to 19.9% under the Investment Agreement). The filing states no transactions by the reporting persons in the past 60 days and adds an amended exhibit (Amended and Restated Annex A).

Blend Labs, Inc. (BLND) Form 3 filed for Ream Jason, who is identified as Head of Finance and Admin and an officer/director of the company. The filing reports the qualifying event date of 08/07/2025 and states that no securities are beneficially owned by the reporting person as of that date. The submission was signed by an attorney-in-fact on 08/15/2025.

Form 144 filing for Blend Labs, Inc. (BLND) reports a proposed sale of 25,000 common shares to be executed through Charles Schwab & Co., Inc. on 08/15/2025 with an aggregate market value of $71,873. The shares were acquired on 02/17/2020 via exercise and hold and fully paid in cash.

The filer previously sold a total of 150,000 shares in six transactions between 06/16/2025 and 07/15/2025, generating aggregate gross proceeds of $503,272. The issuer's reported outstanding shares are 255,696,747, and the planned sale is recorded on the NYSE.

Amendment No. 2 to a Schedule 13G reports current beneficial ownership of Blend Labs, Inc. Class A common stock by several 8VC-related entities and by Joe Lonsdale. The filing shows 8VC Co-Invest LP holds 6,897,728 shares (2.7%) with shared voting and dispositive power, and Opportunities II holds 4,975,791 shares (2.0%) with shared voting and dispositive power. Joe Lonsdale is reported to beneficially own 11,873,519 shares (4.7%) with sole voting and dispositive power over that aggregate amount.

Percentages are calculated on a base of 254,775,978 shares outstanding as of April 30, 2025, as cited in the filing. The reporting persons disclaim beneficial ownership except to the extent of pecuniary interest, and the filing states it only amends the items specified in this Amendment while leaving other previously reported items unchanged.

Winnie Ling, Head of Legal and People at Blend Labs, reported a sale of 4,000 shares of Class A common stock on 08/07/2025. The sale was executed under a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025. The filing reports a weighted average sale price of $3.6192 per share, with sale prices ranging from $3.61 to $3.645 per share and notes that a breakdown of shares sold at each price is available on request.

Following the reported transaction Ling directly beneficially owns 372,018 shares. The disposal reduced her pre-sale direct holding by roughly 1.06%, consistent with a modest, preplanned disposition under an established trading plan rather than an ad hoc sale.